Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
EQS-News: ABIVAX / Key word(s): ConferenceAbivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO) 13.02.2024 / 08:30 CET/CESTThe issuer is solely responsible for the content o.
EQS-News: ABIVAX / Key word(s): AGM/EGMAbivax announces its ordinary and extraordinary general meeting of June 5, 2023, and the availability of the preparatory documents 15.05.2023 / 19:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax announces its ordinary and extraordinary ge.
EQS-News: ABIVAX / Key word(s): MiscellaneousAbivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients 02.05.2023 / 18:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax: Publication of an expert article in JCC on obe.
ABIVAX
Abivax postpones the publication of its 2023 Universal Registration Document 28-Apr-2023 / 19:00 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer. | April 28, 2023